In this study, we demonstrate for the first time that EA, besides exerting anti-proliferative and apoptotic effects, inhibits invasion of the extracellular matrix in response to VEGF-A by human bladder cancer cells. The gene discussed is VEGFA; the disease is urinary bladder cancer.